Latest Aminoacyl tRNA synthetase Stories
Publication in Science Unveils Novel, Diverse and Separate Biological Functions That Can Be Harnessed Therapeutically to Mediate a Wide Range of Human Disease SAN DIEGO and HONG KONG,
SAN DIEGO, July 14, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise announced today, the scientific publication of a splice variant of a tRNA synthetase
Researchers at The Scripps Research Institute (TSRI) say they have uncovered the molecular mechanism that gives ancient herbal malaria cure Chang Shan its healing properties.
Researchers at the University of Gothenburg, Sweden, are working to develop substances that can prevent parasites, bacteria and fungi from producing essential proteins, research that could, in the long term, lead to new drugs for several major diseases.
SAN DIEGO, June 17, 2011 /PRNewswire/ -- aTyr Pharma, an innovative protein therapeutics company, announced today that Red Herring has named the company as a winner of the 2011 Red Herring 100 North America Award, a prestigious list honoring the year's most promising private companies.
SAN DIEGO, May 18, 2011 /PRNewswire/ -- aTyr Pharma, an innovative protein therapeutics company, announced today that Melissa Ashlock, M.D., has joined as vice president, external scientific alliances and human genetics. Dr.